In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

Published:2000-06 Issue:4 Volume:109 Page:729-735
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Voso Maria Teresa,Pantel Gitta,Weis Mirjam,Schmidt Petra,Martin Simona,Moos Marion,Ho Anthony D.,Haas Rainer,Hohaus Stefan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.02084.x/fullpdf

Reference23 articles.

1. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor prognosis follicular lymphoma;Bastion;Blood,1995

2. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody;Buchsbaum;Cancer Research,1992

3. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy;Czuczman;Journal of Clinical Oncology,1999

4. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy;Dana;Journal of Clinical Oncology,1993

5. Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs;Demidem;Cancer Biotherapy and Radiopharmaceuticals,1997

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of prednisolone and rituximab in nephrotic syndrome based on novel nanomaterials;Materials Express;2020-05-01

2. R‐High‐ CHOP / CHASER / LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY;Cancer Science;2018-07-28

3. Preparative regimens for lymphoma;Clinical Guide to Transplantation in Lymphoma;2015-05-15

4. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study;British Journal of Haematology;2014-12-28

5. High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma;Annals of Oncology;2010-11